戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 vanted vaccine based on natural grass pollen allergen extract.
2 later challenged intranasally with cockroach allergen extract.
3 y has broader applicability to other complex allergen extracts.
4  Bla g 3, Bla g 4, and Bla g 5) in crude GCr allergen extracts.
5  been limited by the poor quality of natural allergen extracts.
6 able size from aqueous solutions of licensed allergen extracts.
7 allergies is commonly performed with natural allergen extracts.
8 est performance is related to the quality of allergen extracts.
9  outcome of SPT is related to the quality of allergen extracts.
10 e binding activity of purified allergens and allergen extracts.
11  1-2-4-6 can induce tolerance to complex dog allergen extracts.
12 t alternative to frequent administrations of allergen extracts.
13 al report of the subcutaneous application of allergen extracts, allergen immunotherapy (AIT) has evol
14 ollowing traditional methods based on whole- allergen extracts and allergen immunotherapy is discusse
15 both characterization and standardization of allergen extracts and assay technology have improved.
16 easure all known GCr allergens in commercial allergen extracts and environmental samples.
17       Using mass spectrometry and MRM, mouse allergen extracts and urine samples are shown to be comp
18 al epithelial (HBE) cells were cultured with allergen extracts, and their ACh production and IL-33 se
19 lergen extracts of fungi compared with other allergen extracts, and there are no data on the major al
20 re produced in rabbits using eight different allergens, extracts, and allergen mixtures including mit
21                       German cockroach (GCr) allergen extracts are complex and heterogeneous products
22 With respect to assay performance, ImmunoCAP allergen extracts are good screening tools, but allergen
23 ustering method, we have recently shown that allergen extracts are highly cross-reactive.
24                           However, ImmunoCAP allergen extracts are limited to the composition of the
25                                   Commercial allergen extracts are manufactured by extracting protein
26                   In the United States, most allergen extracts are non-standardized.
27                                 Standardized allergen extracts are recommended for allergen immunothe
28                                   In Europe, allergen extracts are standardized based on skin prick w
29                                              Allergen extracts are the primary tool for diagnosis and
30                                              Allergen extracts are used to study T helper (Th2) cell
31                       Tablet formulations of allergen extracts are widely recommended over other form
32 d decided that manufacturers can label a HDM allergen extract as having a titer of 100000 JAU/ml if i
33   In addition, we discuss of house dust mite allergen extracts as a prototypical complex extract that
34 es in rabbits was compared to three licensed allergen extract-based AIT vaccines.
35                              In this region, allergen extract-based diagnosis is often complicated by
36 piratory diseases, which can be managed with allergen extract-based diagnostics and immunotherapy.
37                                     Using an allergen extract-based test, a glycan and an allergen (g
38 genic and superior over currently registered allergen extract-based vaccines regarding the induction
39 rgens than six to fifteen immunizations with allergen extract-based vaccines.
40 o 30 injections of six licensed birch pollen allergen extract-based vaccines.
41 ALB/c mice were sensitized to a birch pollen allergen extract (BPEx), then received either intranasal
42 years were analyzed for IgE sensitization to allergen extracts by ImmunoCAP.
43 lled trials (RCTs) of SIT using standardized allergen extracts, compared with placebo/control, for tr
44 l mucosa is challenged by local injection of allergen extracts, could identify individuals with esoph
45 signaling activation in airways in cockroach allergen extract (CRE)-induced mouse models.
46 rces and by skin prick testing (SPT) with 10 allergen extracts (English plantain, mugwort, ragweed, t
47  safety and effectiveness of nonstandardized allergen extracts, FDA-reviewed available literature, an
48 cutaneous injection of increasing amounts of allergen extract, followed by maintenance injections ove
49                                   Commercial allergen extracts for allergy skin prick testing (SPT) a
50 ional guidelines, almost all nonstandardized allergen extracts for diagnosis and therapy appear to be
51          Diagnosis and treatment is based on allergen extracts from natural sources where composition
52 tified Dectin-2 as a receptor for glycans in allergen extracts from the house dust mite Dermatophagoi
53 e exposure of Rag1-/- mice to the Alternaria allergen extract generated a form of memory that elicite
54 Immune therapy of allergic patients with dog allergen extracts has shown limited therapeutic benefit.
55                              Nonstandardized allergen extracts have been used for a century.
56 ll responses to the individual components of allergen extracts have not been fully elucidated in subc
57 ed for detecting specific IgE (sIgE) both to allergen extracts (ImmunoCAPsIgE) and to allergen compon
58 ted immunotherapy with a mixture of multiple allergen extracts in 121 perennial asthmatic children.
59 rable results for more than 20 allergens and allergen extracts in three diagnostic systems for the de
60                                          Dog allergen extracts induce robust T(H) 2 and T(H) 17 cell-
61 f sensitization prevalence, correlation, and allergen extract inhibition were performed in patients s
62                     Direct administration of allergen extracts into lymph nodes induces increased spe
63  In high-income, temperate countries, IgE to allergen extracts is a risk factor for, and mediator of,
64 s immunotherapy with depigmented polymerized allergen extracts is a safe and clinically effective tre
65 he regulatory framework regarding diagnostic allergen extracts is currently in the process of being i
66 seasonal rhinoconjunctivitis with unmodified allergen extracts is effective, but limited by risk of s
67  expenses for the registration of diagnostic allergen extracts may render extract production unprofit
68  season 2009, patients received six patches (allergen extract: n = 48; placebo: n = 50) with weekly i
69 luster immunotherapy with a high polymerized allergen extract of a grass/rye pollen mixture have been
70 med with whole blood samples stimulated with allergen extracts of each nut (0.001-1000 ng/mL protein)
71 med with whole blood samples stimulated with allergen extracts of each nut.
72 cy and safety of specific immunotherapy with allergen extracts of fungi compared with other allergen
73 d the documentation of specific IgE to whole allergen extract or single allergens is often ambiguous,
74                                       Native allergen extracts or chemically modified allergoids are
75 D blocker may be worthwhile wherever natural allergen extracts or components are used.
76 atile disc (DVD) to immobilize a panel of 12 allergen extracts or pure proteins in microarray format,
77 al investigation of therapy with more than 2 allergen extracts (particularly in sublingual allergen i
78 g studies for other pollens might start with allergen extracts producing 1.1 cm(2) wheal surface.
79 ms than results of IgE tests with cat or dog allergen extract, respectively.
80                           LC/HRMS of 4 mouse allergen extracts revealed surprising heterogeneity.
81                                   Among 1269 allergen extracts reviewed, there were 480 for which use
82                                              Allergen extracts should be diluted locally prior to adm
83 even in those with the same sensitization to allergen extract SPT or sIgE.
84  sublingual tablets of house dust mite (HDM) allergen extracts (STG320) were efficacious in treating
85 infected individuals for IgE measurements to allergen extracts that contained proteins with high leve
86 d to the conventional AIT with noncapsulated allergen extracts: The protein/DNA molecule can be prote
87 lves the injection of increasing doses of an allergen extract to allergic individuals.
88 er skin test methodology and interpretation, allergen extracts to be used, as well as indications in
89 d to ensure the availability of high-quality allergen extracts to maintain the common diagnostic proc
90 ociated with IgE sensitization to any common allergen extract up to age 16 years.
91 eports, including 13 deaths, associated with allergen extract use over 23 years.
92 trypsin-like proteinases in German cockroach allergen extracts used for clinical skin tests.
93 ion is needed to document the consistency of allergen extracts used for immunotherapy.
94 th 500IR and 300IR sublingual tablets of HDM allergen extracts was efficacious and well tolerated.
95  1) and group 2 major allergens in eight HDM allergen extracts were measured by sandwich ELISAs.
96           Currently licensed nonstandardized allergen extracts were reviewed according to extract typ
97 fety and efficacy, some AIT products contain allergen extracts which are chemically cross-linked to g
98     There is an urgent need for standardized allergen extracts, which will improve the diagnosis and
99 ion provides a new standard for labelling of allergen extracts, which will inform patient care, enabl
100  The efficacy and safety of commercial mouse allergen extracts will be improved with better controls
101 cant and saturable bindings of allergens and allergen extracts with variable binding activities to DC
102 rs ago, focus has been on standardization of allergen extracts, with reliable molecular composition o

 
Page Top